Changzhou Longli Medical Technology Co., Ltd. is located in the middle of Jiangsu Province, the middle section of the Shanghai-Nanjing line in the Yangtze River Delta, and is known as the “Zhongwu Zhifu and the Eight Diagrams Famous Capital”. It has very convenient transportation by sea, land and air. The company covers an area of 20,000.
Company footprint
Company employees
Cooperation customer
The company's main products are: single-use sterile syringe (with needle), disposable sterile drug injection syringe (with needle), disposable sterile injection needle, disposable sterile infusion needle (double wings), one-time use Lumbar puncture needles, and other products of dozens of specifications.
We always take "providing customers with safe and high-quality products" as our mission, adhering to the quality policy of strict management, sincere service, excellence, enterprising and innovative, to provide our customers with quality products and good service.
(Summary description)In recent years, the integration of the health care industry and the electronic information industry has become increasingly close. People's demand for health care has begun to become higher and higher, from simple measurement of patients' physical indicators to early prevention of high-risk populations. The deepening of the concept of electronic informationization of medical equipment is most directly reflected in medical device products.
(Summary description)The import of medical equipment has increased substantially. The existing system defects restrict the development of domestic industry. It is learned from Shenzhen Customs that after the introduction of the national medical reform policy, the state has increased the investment in medical equipment and equipment and the domestic
Frontline nurses in hospital clinics need to complete a large number of medical fluid injections, blood collection, etc. in order to avoid the spread of blood-borne diseases and AIDS in patients or people, and to avoid needle-exposed thorns during collection and treatment. Medelai developed a safe retraction syringe for pathogenic cross-contamination and social harm caused by medical staff or recycling personnel.